ABBOTT LABORATORIES — Director's Dealing 2007

Feb 21, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-02-15

Reporting Person: NEMMERS JOSEPH M (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-02-15	Common shares without par value	S	1500	$52.81	Disposed	81032	Direct
2007-02-16	Common shares without par value	A	27600	$52.54	Acquired	108632	Direct
2007-02-16	Common shares without par value	A	21000	$52.54	Acquired	129632	Direct
2007-02-15	Common shares without par value	F	5169	$52.70	Disposed	124463	Direct
2007-02-17	Common shares without par value	F	3486	$52.49	Disposed	120977	Direct
2007-02-18	Common shares without par value	F	1222	$52.49	Disposed	119755	Direct
2007-02-20	Common shares without par value	F	3156	$52.49	Disposed	116599	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-02-16	Option (right to buy)	$52.54	A	112000	Acquired	2017-02-15	common shares (112000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares without par value	11178	Indirect
Common Shares without par value	355	Indirect
Common Shares without par value	298	Indirect
Common Shares without par value	291	Indirect

Footnotes

F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

F2: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.

F3: Balance in the Abbott Laboratories Stock Retirement Trust as of February 16, 2007.

F4: Reporting person disclaims beneficial ownership of all securities held by his sons.

F5: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11.

F6: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 37,334 on 2/16/2008, 37,333 on 2/16/09, and 37,333 on 2/16/10.